In its efforts to enter the US and European markets, Natco Pharma Ltd has signed a into a letter of intent (LoI)with the US-based Akorn, Inc, (located in Buffalo Grove) to develop and supply two ANDA oral tablet drug .
Click the following link http://ww4.6URL.com/09QF to read the complete article.


